The ERBB network facilitates KRAS-driven lung tumorigenesis

KRAS is the most frequently mutated driver oncogene in human adenocarcinoma of the lung. There are presently no clinically proven strategies for treatment of KRAS-driven lung cancer. Activating mutations in KRAS are thought to confer independence from upstream signaling, however recent data suggest...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Sci Transl Med
Hoofdauteurs: Kruspig, Björn, Monteverde, Tiziana, Neidler, Sarah, Hock, Andreas, Kerr, Emma, Nixon, Colin, Clark, William, Hedley, Ann, Laing, Sarah, Coffelt, Seth B., Quesne, John Le, Dick, Craig, Vousden, Karen, Martins, Carla P., Murphy, Daniel J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881183/
https://ncbi.nlm.nih.gov/pubmed/29925636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aao2565
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items